Persistence on F/TAF versus F/TDF for HIV Pre-Exposure Prophylaxis (PrEP): A Real-World Evidence Analysis in the United States

Conference Reports for NATAP

ID Week
Wed, Sep 29 -
Sun, Oct 3, 2021
Virtual Conference


Persistence on F/TAF versus F/TDF for HIV Pre-Exposure Prophylaxis (PrEP): A Real-World Evidence Analysis in the United States

	IDWeek 2021, Virtual, September 29 - October 3, 2021 Li Tao, Valentina Shvachko, Moupali Das, Christoph Carter, Jared Baeten, and David Magnuson Gilead Sciences, Inc. Foster City, CA 94404